Sponsors/CROs

Quality, compliance, accuracy, reliability and expertise are all critically important in the world of clinical research. With Quorum’s focus on performance – sponsors, CROs and other funding agencies can rely on Quorum Review IRB to safeguard the rights and well-being of research participants while promptly delivering accurate clinical research study documents.

Initial IRB Submission

Information on initial clinical trial study submission. Submit to Quorum Review IRB for central studies, single site, observation and investigator generated studies.

Research Study Changes

Information on which types of clinical research study changes require submission and how to submit research study changes to Quorum Review IRB.

Continuing Review and Closure

Information regarding continuing review at the protocol level, sponsors / CRO’s continuing review forms and FAQs.

Clinical Trial Safety

Information about Quorum Review IRB safety reporting guidelines, forms, and safety reporting FAQs for sponsors and CRO’s.

Participant Recruitment

Guidance for study sponsors and clinical research organizations on creating and submitting recruitment materials.

Research in Canada

The North American Board complies with Canadian and U.S. requirements and meets every Wednesday to review U.S. and Canadian studies.

FAQs

Common questions and information to help sponsors and clinical research organizations avoid obstacles throughout a research study.

Conflict of Interest

Quorum’s conflict of interest policy attempts to strike a balance between differing agency standards (e.g., FDA, PHS, Health Canada, etc.), relevant guidance, and accreditation standards related to conflict of interest reporting.



 
HII